Voloridge Investment Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,448
| Closed | -$60.9K | – | 1183 |
|
|
2024
Q1 | $60.9K | Buy |
+13,448
| New | +$60.9K | ﹤0.01% | 1116 |
|
|
2023
Q3 | – | Sell |
-97,323
| Closed | -$629K | – | 1346 |
|
|
2023
Q2 | $629K | Sell |
97,323
-27,921
| -22% | -$180K | ﹤0.01% | 1200 |
|
|
2023
Q1 | $944K | Buy |
+125,244
| New | +$944K | ﹤0.01% | 1135 |
|
|
2022
Q3 | – | Sell |
-196,406
| Closed | -$2.09M | – | 1366 |
|
|
2022
Q2 | $2.09M | Buy |
196,406
+66,524
| +51% | +$709K | 0.01% | 999 |
|
|
2022
Q1 | $1.27M | Buy |
+129,882
| New | +$1.27M | 0.01% | 1073 |
|
|
2021
Q3 | – | Sell |
-174,428
| Closed | -$3.84M | – | 1610 |
|
|
2021
Q2 | $3.84M | Buy |
+174,428
| New | +$3.84M | 0.03% | 737 |
|